These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 24721603)
1. Long-term outcomes of extracorporeal shockwave therapy for chronic foot ulcers. Wang CJ; Wu CT; Yang YJ; Liu RT; Kuo YR J Surg Res; 2014 Jun; 189(2):366-72. PubMed ID: 24721603 [TBL] [Abstract][Full Text] [Related]
2. Is Shock Wave Application Effective on Various Chronic Wounds in the Geriatric Population? Preliminary Clinical Study. Dymarek R; Kuberka I; Walewicz K; Taradaj J; Rosińczuk J; Sopel M Clin Interv Aging; 2024; 19():665-679. PubMed ID: 38706636 [TBL] [Abstract][Full Text] [Related]
4. The Efficacy of Extracorporeal Shockwave Therapy Compared with Compression Therapy in Healing Venous Leg Ulcers. Dolibog PT; Dolibog P; Bergler-Czop B; Grzegorczyn S; Chmielewska D J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610882 [No Abstract] [Full Text] [Related]
5. Extracorporeal shockwave therapy in the treatment of chronic diabetic foot ulcers: a prospective randomised trial. Jeppesen SM; Yderstraede KB; Rasmussen BS; Hanna M; Lund L J Wound Care; 2016 Nov; 25(11):641-649. PubMed ID: 27827284 [TBL] [Abstract][Full Text] [Related]
6. A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. Skrepnek GH; Mills JL; Armstrong DG PLoS One; 2015; 10(8):e0134914. PubMed ID: 26248037 [TBL] [Abstract][Full Text] [Related]
7. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. Rice JB; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Skornicki M; Margolis DJ; Parsons NB J Med Econ; 2015; 18(8):586-95. PubMed ID: 25786331 [TBL] [Abstract][Full Text] [Related]
8. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Abe K; Itoyama Y; Sobue G; Tsuji S; Aoki M; Doyu M; Hamada C; Kondo K; Yoneoka T; Akimoto M; Yoshino H; Amyotroph Lateral Scler Frontotemporal Degener; 2014 Dec; 15(7-8):610-7. PubMed ID: 25286015 [TBL] [Abstract][Full Text] [Related]
9. Extracorporeal shockwave therapy in diabetic foot ulcers. Wang CJ; Cheng JH; Kuo YR; Schaden W; Mittermayr R Int J Surg; 2015 Dec; 24(Pt B):207-9. PubMed ID: 26079500 [TBL] [Abstract][Full Text] [Related]
10. Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors. Strand V; Reaney M; Chen CI; Proudfoot CW; Guillonneau S; Bauer D; Mangan E; Graham NM; van Hoogstraten H; Lin Y; Pacheco-Tena C; Fleischmann R RMD Open; 2017; 3(1):e000416. PubMed ID: 28326189 [TBL] [Abstract][Full Text] [Related]
11. Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial. Strand V; Kosinski M; Chen CI; Joseph G; Rendas-Baum R; Graham NM; van Hoogstraten H; Bayliss M; Fan C; Huizinga T; Genovese MC Arthritis Res Ther; 2016 Sep; 18(1):198. PubMed ID: 27600829 [TBL] [Abstract][Full Text] [Related]
12. Feasibility study of sustained-release travoprost punctum plug for intraocular pressure reduction in an Asian population. Perera SA; Ting DS; Nongpiur ME; Chew PT; Aquino MC; Sng CC; Ho SW; Aung T Clin Ophthalmol; 2016; 10():757-64. PubMed ID: 27175058 [TBL] [Abstract][Full Text] [Related]
13. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Andrews KL; Houdek MT; Kiemele LJ Prosthet Orthot Int; 2015 Feb; 39(1):29-39. PubMed ID: 25614499 [TBL] [Abstract][Full Text] [Related]
14. Oral L-glutamine therapy for sickle cell anemia: I. Subjective clinical improvement and favorable change in red cell NAD redox potential. Niihara Y; Zerez CR; Akiyama DS; Tanaka KR Am J Hematol; 1998 Jun; 58(2):117-21. PubMed ID: 9625578 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of shock wave therapy on chronic diabetic foot ulcer: a single-blinded randomized controlled clinical trial. Omar MT; Alghadir A; Al-Wahhabi KK; Al-Askar AB Diabetes Res Clin Pract; 2014 Dec; 106(3):548-54. PubMed ID: 25451894 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Hitchman LH; Totty JP; Raza A; Cai P; Smith GE; Carradice D; Wallace T; Harwood AE; Chetter IC Ann Vasc Surg; 2019 Apr; 56():330-339. PubMed ID: 30496896 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Shock Wave Therapy for Treating Foot Ulcers in Adults With Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Huang Q; Yan P; Xiong H; Shuai T; Liu J; Zhu L; Lu J; Shi X; Yang K; Liu J Can J Diabetes; 2020 Mar; 44(2):196-204.e3. PubMed ID: 31515158 [TBL] [Abstract][Full Text] [Related]
19. Application of extracorporeal shockwave therapy to improve microcirculation in diabetic foot ulcers: A prospective study. Jeong D; Lee JH; Lee GB; Shin KH; Hwang J; Jang SY; Yoo J; Jang WY Medicine (Baltimore); 2023 Mar; 102(11):e33310. PubMed ID: 36930075 [TBL] [Abstract][Full Text] [Related]